Micro, Inventors may own and license out their pa
Post# of 9144
Posted On: 11/18/2016 8:16:39 AM
Micro,
Inventors may own and license out their patents for royalties (to any company they want) - if the inventor is independent of a company. In this case the "inventor" is employed by Nanologix inc. That being said, when someone invents a product/device, etc that is a direct benefit of the the company "that employs them", then the product/device belongs to the company and the inventor receives a royalty back from the company. As I said in my post. If a large company wanted to buy up Nanologix, what would the company be worth without owning it's two main patents. All the large company would be buying is a building (if owned by NNLX and some equipment.) They wouldn't own the patent rights to FlatPack and N-assay. They would have to deal with BB to buy the patents from him in a separate private deal. Which would undoubtedly not be a benefit for the shareholders. No dishonesty about it. Just business facts.
This is not to discredit the company. In fact I think the N-assay is a good idea.
The problem as I see it, is the CEO is running the company as if it was a "private" company. No shareholder meetings, keeping patents in his own name, No BOD elections, no financials, etc. If this was a "private" company it wouldn't matter - but it's NOT.
With all due respect. You can sugar coat all you want but it doesn't change the fact that that BB is not running the company the way a "PUBLIC" company should be.
All in my opinion.
Inventors may own and license out their patents for royalties (to any company they want) - if the inventor is independent of a company. In this case the "inventor" is employed by Nanologix inc. That being said, when someone invents a product/device, etc that is a direct benefit of the the company "that employs them", then the product/device belongs to the company and the inventor receives a royalty back from the company. As I said in my post. If a large company wanted to buy up Nanologix, what would the company be worth without owning it's two main patents. All the large company would be buying is a building (if owned by NNLX and some equipment.) They wouldn't own the patent rights to FlatPack and N-assay. They would have to deal with BB to buy the patents from him in a separate private deal. Which would undoubtedly not be a benefit for the shareholders. No dishonesty about it. Just business facts.
This is not to discredit the company. In fact I think the N-assay is a good idea.
The problem as I see it, is the CEO is running the company as if it was a "private" company. No shareholder meetings, keeping patents in his own name, No BOD elections, no financials, etc. If this was a "private" company it wouldn't matter - but it's NOT.
With all due respect. You can sugar coat all you want but it doesn't change the fact that that BB is not running the company the way a "PUBLIC" company should be.
All in my opinion.
(6)
(2)